Corrigendum to ''Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death" [International Journal of Cardiology 112/2 (2006) 142-152] (DOI:10.1016/j.ijcard.2005.11.106);Roles of cardiac ryanodine receptor in heart failure and sudden cardiac death

International Journal of Cardiology

Volumn 112, Issue 2, 2006, Pages 142-152

  Phrommintikul, Arintaya ^a   Chattipakorn, Nipon ^a,b  

^a Faculty of Medicine Chiang Mai University   (Thailand)

^b THAMMASAT UNIVERSITY   (Thailand)

Author keywords

Calcium; Heart failure; Ryanodine receptor; Sudden death

Indexed keywords

4 [3 (4 BENZYL 1 PIPERIDINYL)PROPIONYL] 2,3,4,5 TETRAHYDRO 7 METHOXY 1,4 BENZOTHIAZEPINE; ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALBINDIN; CALCIUM ION; CALSEQUESTRIN; CALSTABIN1; CALSTABIN2; CYCLIC AMP DEPENDENT PROTEIN KINASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; PROPRANOLOL; PROTEIN KINASE (CALCIUM,CALMODULIN) II; REGULATOR PROTEIN; RYANODINE RECEPTOR; SORCIN; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

ADRENERGIC SYSTEM; CALCIUM TRANSPORT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; DEFIBRILLATOR; HEART ARRHYTHMIA; HEART CONTRACTION; HEART DEPOLARIZATION; HEART FAILURE; HEART INNERVATION; HEART MUSCLE CONTRACTILITY; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SARCOPLASMIC RETICULUM; SUDDEN DEATH;

EID: 33748446380     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2007.07.022     Document Type: Erratum

References (98)

1. Majeed A., Williams J., de Lusignan S., et al. Management of heart failure in primary care after implementation of the National Service Framework for Coronary Heart Disease: a cross-sectional study. Public Health 119 (2005) 105-111
2. McMurray J.J., and Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 83 (2000) 596-602
3. Cleland J.G., and Clark A.L. Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth. J Am Coll Cardiol 42 (2003) 1234-1237
4. Wehrens X.H., Lehnart S.E., and Marks A.R. Intracellular calcium release channels and cardiac disease. Annu Rev Physiol 67 (2005) 69-98
5. 2+ release, but normal ryanodine receptors, in canine and human heart failure. Circ Res 91 (2002) 1015-1022
6. 2+ release from cardiac sarcoplasmic reticulum in tachycardia-induced heart failure. Cardiovasc Res 44 (1999) 146-155
7. Fabiato A. Calcium-induced release of calcium from the cardiac sarcoplasmic reticulum. Am J Physiol 245 (1983) C1-C14
8. Bers D.M. Cardiac excitation-contraction coupling. Nature 415 (2002) 198-205
9. 2+ release from the sarcoplasmic reticulum in guinea-pig ventricular myocytes. J Physiol 508 Pt 2 (1998) 439-451
10. Terentyev D., Viatchenko-Karpinski S., Gyorke I., et al. Protein phosphatases decrease sarcoplasmic reticulum calcium content by stimulating calcium release in cardiac myocytes. J Physiol 552 (2003) 109-118
11. Simmerman H.K., and Jones L.R. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev 78 (1998) 921-947
12. Stern M.D., and Cheng H. Putting out the fire: what terminates calcium-induced calcium release in cardiac muscle?. Cell Calcium 35 (2004) 591-601
13. Farrell E.F., Arrieta M.I., Reuda A., et al. Sorcin inhibits calcium release and modulates excitation-contraction coupling in the heart. J Biol Chem 278 (2003) 34660-34666
14. Fabiato A. Time and calcium dependent of activation and inactivation of calcium-induced release of calcium from a sarcoplasmic reticulum of a skinned canine cardiac purkinje cell. J Gen Physiol 85 (1985) 247-289
15. 2+ in single ventricular myocytes. Am J Physiol 258 (1990) 189-193
16. 2+ inhibits the ryanodine receptor from cardiac muscle. J Membr Biol 147 (1995) 7-22
17. 2+ relaese in heart. Science 260 (1993) 987-988
18. Fill M., Zahradnikova A., Villalba-Galera C.A., et al. Ryanodine receptor adaptation. J Gen Physiol 116 (2000) 873-882
19. Tunwell R.E., Wickenden C., Bertrand B.M., et al. The human cardiac muscle ryanodine receptor-calcium release channel: identification, primary structure and topological analysis. Biochem J 318 Pt 2 (1996) 477-487
20. Giannini G., and Sorrentino V. Molecular structure and tissue distribution of ryanodine receptors calcium channels. Med Res Rev 15 (1995) 313-323
21. 2+ release channe; (ryanodine channel) in human myocardium. J Mol Med 78 (2000) 352-360
22. 2+ release units and couplons in skeletal and cardiac muscles. Biophys J 77 (1999) 1528-1539
23. Dulhunty A.F., Karunasekara Y., Curtis S.M., et al. The recombinant dihydropyridine receptor II-III loop and partly structured 'C' region peptides modify cardiac ryanodine receptor activity. Biochem J 385 (2005) 803-813
24. Bers D.M. Macromolecular complexes regulating cardiac ryanodine receptor function. J Mol Cell Cardiol 37 (2004) 417-429
25. Chelu M.G., Danila C.I., Gilman C.P., et al. Regulation of ryanodine receptors by FK506 binding proteins. Trends Cardiovasc Med 14 (2004) 227-234
26. Jeyakumar L.H., Ballester L., Cheng D.S., et al. FKBP binding characteristics of cardiac microsomes from diverse vertebrates. Biochem Biophys Res Commun 281 (2001) 979-986
27. Timerman A.P., Onoue H., Xin H.B., et al. Selective binding of FKBP12.6 by the cardiac ryanodine receptor. J Biol Chem 271 (1996) 20385-20391
28. 2+ release channel (ryanodine receptor). J Biol Chem 278 (2003) 3786-3792
29. Zissimopoulos S., and Lai F.A. Interaction of FKBP12.6 with the cardiac ryanodine receptor C-terminal domain. J Biol Chem 280 (2005) 5475-5485
30. Marx S.O., Gaburjakova J., Gaburjakova M., et al. Coupled gating between cardiac calcium release channels (ryanodine receptors). Circ Res 88 (2001) 1151-1158
31. Brillantes A.B., Ondrias K., Scott A., et al. Stabilization of calcium release channel (ryanodine receptor) function by FK506-binding protein. Cell 77 (1994) 513-523
32. 2+ release channel closure in rat heart. J Physiol 500 Pt 2 (1997) 343-354
33. 2+ leak from the sarcoplasmic reticulum and increases contractility. Circ Res 88 (2001) 188-194
34. Loughrey C.M., Seidler T., Miller S.L.W., et al. Over-expression of FK 506 binding-protein FKBP 12.6 alters excitation-contraction coupling in adult rabbit cardiomyocyte. J Physiol 556 (2004) 919-934
35. Xin H.B., Senbonmatsu T., Cheng D.S., et al. Oestrogen protects FKBP12.6 null mice from cardiac hypertrophy. Nature 416 (2002) 334-338
36. 2+)i differ in mouse and rabbit ventricular myocytes. J Pharmacol Exp Ther 304 (2003) 334-341
37. Shou W., Aghdasi B., Armstrong D.L., et al. Cardiac defects and altered ryanodine redeptor function in mice lacking FKBP12. Nature 39 (1998) 489-492
38. Marx S.O., Reiken S., Hisamatsu Y., et al. Phosphorylation-dependent regulation of ryanodine receptors: a novel role for leucine/isoleucine zippers. J Cell Biol 153 (2001) 699-708
39. Marx S.O., Reiken S., Hisamatsu Y., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101 (2000) 365-376
40. 2+-release channel (ryanodine receptor) does not dissociate 12.6-kDa FK506-binding protein (FKBP12.6). Circ Res 94 (2004) 487-495
41. 2+ current trigger. J Physiol 556 (2004) 463-480
42. duBell W.H., Lederer W.J., and Rogers T.B. Dynamic modulation of excitation-contraction coupling by protein phosphatases in rat ventricular myocytes. J Physiol 493 Pt 3 (1996) 793-800
43. Hain J., Onoue H., Mayrleitner M., et al. Phosphorylation modulates the function of the calcium release channel of sarcoplasmic reticulum from cardiac muscle. J Biol Chem 270 (1995) 2074-2081
44. 2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ Res 94 (2004) e61-e70
45. Currie S., Loughrey C.M., Craig M.A., et al. Calcium/calmodulin-dependent protein kinase IIdelta associates with the ryanodine receptor complex and regulates channel function in rabbit heart. Biochem J 377 (2004) 357-366
46. Meyer T., Hanson P.I., Stryer L., et al. Calmodulin trapping by calciumcalmodulin-dependent protein kinase. Science 256 (1992) 1199-1202
47. Wu Y., Colbran R.J., and Anderson M.E. Calmodulin kinase is a molecular switch for cardiac excitation-contraction coupling. Proc Natl Acad Sci U S A 98 (2001) 2877-2881
48. 2+-ATPase and modulates excitation-contraction coupling in the heart. Basic Res Cardiol 100 (2005) 250-262
49. Frank K.F., Block B., Ding Z., et al. Overexpression of sorcin enhances cardiac contractility in vivo and in vitro. J Mol Cell Cardiol 38 (2005) 607-615
50. Meyer M.B., Fischer A., Sun Y., et al. Sorcin regulated excitation-contraction coupling in the heart. J Biol Chem 278 (2003) 28865-28871
51. 2+ buffer inside the sarcoplasmic reticulum. Biochem J 337 Pt 1 (1999) 19-22
52. Kubalova Z., Gyorke I., Terentyeva R., et al. Modulation of cytoplasmic and intra-sarcoplasmic reticulum calcium waves by calsequestrin in rat cardiac myocytes. J Physiol 561.2 (2004) 515-524
53. Viatchenko-Karpinski S., Terentyev D., Gyorke I., et al. Abnormal calcium signaling and sudden cardiac death associated with mutation of calsequestrin. Circ Res 94 (2004) 471-477
54. 2+ release (SOICR). Proc Natl Acad Sci U S A 101 (2004) 13062-13067
55. Murphy E., Steenbergen C., Levy L.A., et al. Cytosolic free magnesium levels in ischemic rat heart. J Biol Chem 264 (1989) 5622-5627
56. 2+, and adenine nucleotides under normal and simulated ischemic conditions. Circ Res 79 (1996) 1100-1109
57. Hare J.M. Nitric oxide and excitation-contraction coupling. J Mol Cell Cardiol 35 (2003) 719-729
58. Zahradnikova A., Minarovic I., Venema R.C., et al. Inactivation of the cardiac ryanodine receptor calcium release channel by nitric oxide. Cell Calcium 22 (1997) 447-454
59. Barouch L.A., Harrison R.W., Skaf M.W., et al. Nitric oxide regulates the heart by spatial confinement of nitirc oxide synthase isoforms. Nature 416 (2002) 340
60. Wehrens X.H., Lehnart S.E., Reiken S.R., et al. Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. Science 304 (2004) 292-296
61. Li Y., Kranias E.G., Mignery G.A., et al. Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes. Circ Res 90 (2002) 309-316
62. Dzhura I., Wu Y., Colbran R.J., et al. Calmodulin kinase determines calcium-dependent facilitation of L-type calcium channels. Nat Cell Biol 2 (2000) 173-177
63. 2+-ATPase in failing and nonfailing human myocardium. Circ Res 75 (1994) 434-442
64. Reiken S., Gaburjakova M., Guatimosim S., et al. Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. J Biol Chem 278 (2003) 444-453
65. Hasenfuss G. Alterations of calcium-regulatory proteins in heart failure. Cardiovasc Res 37 (1998) 279-289
66. Lehnart S.E., Wehrens X.H., Kushnir A., et al. Cardiac ryanodine receptor function and regulation in heart disease. Ann N Y Acad Sci 1015 (2004) 144-159
67. Doi M., Yano M., Kobayashi S., et al. Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor. Circulation 105 (2002) 1374-1379
68. 2+ release in heart failure. Cardiovasc Res 48 (2000) 323-331
69. 2+ leak through ryanodine receptor in heart failure. Circulation 102 (2000) 2131-2136
70. Gomez A.M., Valdivia H.H., Cheng H., et al. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276 (1997) 800-806
71. Gomez A.M., Guatimosim S., Dilly K.W., et al. Heart failure after myocardial infarction: altered excitation-contraction coupling. Circulation 104 (2001) 688-693
72. Hasenfuss G., Mulieri L.A., Leavitt B.J., et al. Alteration of contractile function and excitation-contraction coupling in dilated cardiomyopathy. Circ Res 70 (1992) 1225-1232
73. 2+ content in isolated failing and nonfailing human myocardium. Circ Res 85 (1999) 38-46
74. 2+ transients in failing human myocardium assessed with ryanodine. J Mol Cell Cardiol 30 (1998) 1285-1294
75. Wehrens X.H., Lehnart S.E., Huang F., et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 113 (2003) 829-840
76. Matsuda H., Noma A., Kurachi Y., et al. Transient depolarization and spontaneous voltage fluctuations in isolated single cells from guinea pig ventricles. Calcium-mediated membrane potential fluctuations. Circ Res 51 (1982) 142-151
77. Giles W., and Shimoni Y. Comparison of sodium-calcium exchanger and transient inward currents in single cells from rabbit ventricle. J Physiol 417 (1989) 465-481
78. Zygmunt A.C. Intracellular calcium activates a chloride current in canine ventricular myocytes. Am J Physiol 267 (1994) H1984-H1995
79. 2+ channels and ryanodine receptors in rat ventricular myocytes. J Gen Physiol 108 (1996) 435-454
80. 2+ channels on early after-depolarizations. Biophys J 88 (2005) 85-95
81. Hjalmarson A., Goldstein S., Fagerberg B., et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA 283 (2000) 1295-1302
82. Garg R., and Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 273 (1995) 1450-1456
83. Pitt B., Zannad F., Remme W.J., et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 341 (1999) 709-717
84. McAlister F.A., Ezekowitz J.A., Wiebe N., et al. Systematic review: cardiac resynchronization in patients with symptomatic heart failure. Ann Intern Med 141 (2004) 381-390
85. Bellenger N.G., Rajappan K., Rahman S.L., et al. Effects of carvedilol on left ventricular remodelling in chronic stable heart failure: a cardiovascular magnetic resonance study. Heart 90 (2004) 760-764
86. Reiken S., Wehrens X.H., Vest J.A., et al. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 107 (2003) 2459-2466
87. Reiken S., Gaburjakova M., Gaburjakova J., et al. Beta-adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure. Circulation 104 (2001) 2843-2848
88. Kohno M., Yano M., Kobayashi S., et al. A new cardioprotective agent, JTV519, improves defective channel gating of ryanodine receptor in heart failure. Am J Physiol Heart Circ Physiol 284 (2003) H1035-H1042
89. Yano M., Kobayashi S., Kohno M., et al. FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107 (2003) 477-484
90. Zipes D.P., and Wellens H.J. Sudden cardiac death. Circulation 98 (1998) 2334-2351
91. Tiso N., Stephan D.A., Nava A., et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 10 (2001) 189-194
92. Yano M., Yamamoto T., Ikemoto N., et al. Abnormal ryanodine receptor function in heart failure. Pharmacol Ther 107 (2005) 377-391
93. Priori S.G., Napolitano C., Memmi M., et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 106 (2002) 69-74
94. Laitinen P.J., Brown K.M., Piippo K., et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 103 (2001) 485-490
95. Priori S.G., Napolitano C., Tiso N., et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 103 (2001) 196-200
96. Lehnart S.E., Wehrens X.H., Laitinen P.J., et al. Sudden death in familial polymorphic ventricular tachycardia associated with calcium release channel (ryanodine receptor) leak. Circulation 109 (2004) 3208-3214
97. George C.H., Higgs G.V., and Lai F.A. Ryanodine receptor mutations associated with stress-induced ventricular tachycardia mediate increased calcium release in stimulated cardiomyocytes. Circ Res 93 (2003) 531-540
98. Thomas N.L., Christopher H., and George F.A.L. Functional heterogeneity of ryanodine receptor mutations associated with sudden cardiac death. Cardiovasc Res. 64 (2004) 52-60